Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Financing › Details

Univ Florida–Agilent: grant, 201507– Thought Leader Award to Lawrence Lesko at College of Pharmacy for biomarker research

 

Period Period 2015-07-15
Region Region Orlando, FL
  Country United States (USA)
Organisation Money taker University of Florida, College of Pharmacy (Orlando)
  Group University of Florida
Products Product hybrid Quad-ToF (QTOF) mass spectrometer
  Product 2 biomarker discovery services
Index term Index term Univ Florida–Agilent: mass spectrometer, 201507 supply existent use of Agilent accurate mass Q-TOF LC/MS w Mass Profiler Prof + Pathway Architect s/w
Person Person Lesko, Lawrence J. (Univ Florida 201507 Director of Center for Pharmacometrics + Systems Pharmacology)
     

Agilent Technologies Inc.. (7/15/15). "Press Release: Agilent Technologies Presents Thought Leader Award to Renowned Systems Pharmacologist Lawrence Lesko". Santa Clara, CA.

Award Supports Search for Biomarkers to Better Predict Side Effects of New Medicines


Agilent Technologies Inc. (NYSE: A) announced today that Dr. Lawrence J. Lesko has received an Agilent Thought Leader Award in support of his research into preclinical toxicological assessments of new medicines.

An internationally recognized pharmacologist, Dr. Lesko directs the Center for Pharmacometrics and Systems Pharmacology at the University of Florida's College of Pharmacy in Orlando.

"We are pleased to support Dr. Lesko's research, which is addressing important needs in the rapidly evolving field of systems toxicology," said Monty Benefiel, Agilent vice president and general manager of the Mass Spectrometry Division. Benefiel is the executive sponsor of this award.

Dr. Lesko and his team are using Agilent accurate mass Q-TOF LC/MS to collect and analyze metabolomics data. With the help of Agilent's Mass Profiler Professional and Pathway Architect software, they hope to discover biomarker panels that could enable the development of future companion diagnostics.

"I am very pleased and appreciative of Agilent's Thought Leader Award," said Dr. Lesko. "It enables our team to identify metabolomic safety biomarkers of drug-induced renal toxicity and the mechanisms by which these toxicities occur. This research will lead us to identifying at-risk patients and exploring the use of concomitantly administered medicines as protectants against drug-induced renal damage. It could have a major effect on improving drug development and clinical care."

Kidney toxicity is a leading cause of formerly approved drugs being withdrawn from the market. Although a few clinical biomarkers of kidney injury are available, they lack adequate sensitivity or specificity. Dr. Lesko and his team want to identify novel biomarkers that could not only help drug makers better assess new drug candidates but might eventually enable doctors to better manage treatments.


The Agilent Thought Leader Award promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences, diagnostics and chemical analysis. Information about previous award recipients is available at Agilent's Thought Leader website.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.0 billion in fiscal 2014 and employs about 12,000 people worldwide. Agilent marks its 50th anniversary in analytical instrumentation this year. Information about Agilent is available at www.agilent.com.

# # #

Contact:

Victoria Wadsworth-Hansen
+1 408 553 2005
victoria.wadsworth-hansen@agilent.com

   
Record changed: 2016-05-15

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for University of Florida


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px




» top